Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hematopoiesis is the process of blood cell formation, including erythrocytes (red blood cells), leukocytes (white blood cells, including lymphocytes, granulocytes, and monocytes), and thrombocytes (platelets). This process occurs mainly in the bone marrow in adults and is regulated by a complex interplay of stem cell signaling, growth factors (such as erythropoietin and G-CSF), cytokines, and the bone marrow microenvironment[1][5][6]. While many approved drugs and biologicals are used to stimulate or support hematopoiesis in conditions such as anemia, neutropenia, or after chemotherapy, "hematopoiesis support" itself does not refer to a discrete molecular target, but rather a therapeutic goal or intervention area[2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hematopoiesis support.